Alerts will be sent to your verified email
Verify EmailCRAVATEX
Cravatex
|
Newjaisa Tech
|
Remedium Lifecare
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
44.29 % | 63.32 % | 34.22 % |
5yr average Equity Multiplier
|
-3.38 | 2.58 | 42.65 |
5yr Average Asset Turnover Ratio
|
1.91 | 2.69 | 1.56 |
5yr Avg Net Profit Margin
|
1.55 % | 9.86 % | 2.44 % |
Price to Book
|
1.09 | 0.0 | 2.64 |
P/E
|
39.1 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
24.82 Days | 136.07 Days | 19.37 Days |
Inventory Days
|
43.2 Days | 59.95 Days | 27.07 Days |
Days Receivable
|
39.71 Days | 42.24 Days | 49.35 Days |
Days Payable
|
34.03 Days | 15.08 Days | 59.73 Days |
5yr Average Interest Coverage Ratio
|
7.28 | 11.36 | 25.1 |
5yr Avg ROCE
|
-6.95 % | 92.31 % | 50.97 % |
5yr Avg Operating Profit Margin
|
-2.69 % | 14.05 % | 3.37 % |
5 yr average Debt to Equity
|
-1.77 | 0.96 | 0.83 |
5yr CAGR Net Profit
|
n/a | 53.99 % | 159.15 % |
5yr Average Return on Assets
|
7.41 % | 23.49 % | 2.07 % |
Shareholdings
|
|||
Promoter Holding
|
75.0 % | 62.89 % | 1.13 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -6.46 % | 0.02 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Cravatex
|
Newjaisa Tech
|
Remedium Lifecare
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|